Paclitaxel, cisplatin, and 5-fluorouracil (5-FU) are standard anti-HNSCC drugs [1], the efficacies of which are limited by several ABC-transporters at least in vitro [3]–[8]. The gene discussed is ABCG2; the disease is head and neck squamous cell carcinoma.